Recent economic stressors are challenging the biopharma R&D pipeline, forcing many companies to make tough strategic decisions and unprecedented cuts to R&D programs. While we canâ
In this blog, weâ€™ll break down some of the key terms and concepts youâ€™ll need to know to speak and write about biomanufacturing and bioprocessing.
Weâ€™ve all had enough of talk of the past! Letâ€™s look at what the future might hold for the life science industry â€“ and its marketers â€“ under the policy changes promised by
Four years ago, Erik Clausen, CG Life Managing Partner, predicted the Trump Administration's impact on the Life Sciences and it's marketers (like us). Find if he was right in this
The media landscape is extremely noisy, yet your job is to figure out how to generate visibility for your organization. So, how do you set your company up for maximum media coverag
The growing role of science and technology in public life has created a scenario where the scientific and medical communities can not afford to ignore public distrust. This post ex
To better understand how how life science and healthcare sales have been affected by our new "normal," we sat down with a number of sales managers to hear their predictions for the
In recognition of Women's History Month and International Women's Day 2020, the CG Life team shares personal stories about Women in STEM that inspire our team.